The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,284
Sort by:
Immunotherapy Market Forecasts to 2034 – Global Analysis By Therapy Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors, Cancer Vaccines, Cell-based Therapies, Cytokine-based Therapies, Oncolytic Virus Therapy, and Other Therapy Types), Route of Administration, Application, End User, Distribution Channel, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Immunotherapy Market is accounted for $246.3 billion in 2026 and is expected to reach $555.4 billion by 2034 growing at a CAGR of 10.7% during the forecast per...
May 2026
200 pages
Global Polymyxin B Market Growth 2026-2032
US$ 3,660.00
The global Polymyxin B market size is predicted to grow from US$ 55.37 million in 2025 to US$ 47.60 million in 2032; it is expected to grow at a CAGR of -2.2% from 2026 to 2032. Polymyxin B is a catio...
May 2026
94 pages
Global Meropenem for Injection Market Growth 2026-2032
US$ 3,660.00
The global Meropenem for Injection market size is predicted to grow from US$ 1804 million in 2025 to US$ 2443 million in 2032; it is expected to grow at a CAGR of 4.5% from 2026 to 2032. Meropenem for...
May 2026
96 pages
Global Modified NSAIDs Market Growth 2026-2032
US$ 3,660.00
The global Modified NSAIDs market size is predicted to grow from US$ 7169 million in 2025 to US$ 12144 million in 2032; it is expected to grow at a CAGR of 8.3% from 2026 to 2032. Modified nonsteroida...
May 2026
153 pages
Active Pharmaceutical Ingredient Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Synthesis (Biotech, Fermentation, Plant Extracts, Synthetic), By Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Active Pharmaceutical Ingredient (API) Market is anticipated to expand from USD 160.91 billion in 2025 to USD 241.21 billion by 2031, exhibiting a compound annual growth rate of 6.98%. APIs...
May 2026
177 pages
Intravenous Iron Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Iron Dextran, Ferric Gluconate, Iron Sucrose, Ferric Carboxymaltos, Iron Isomaltoside 1000, Ferumoxytol), By Application (Intestinal Malabsorption Syndromes, Inflammatory Diseases, Gastrectomy/Bariatric Surgery, Anemia, Osier-Weber-Rendu Disease, Angiodysplasia, Pregnancy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Intravenous Iron Drugs Market is anticipated to expand from USD 2.55 billion in 2025 to USD 3.57 billion by 2031, reflecting a compound annual growth rate (CAGR) of 5.77%. Administered dire...
May 2026
185 pages
Oral Clinical Nutrition Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Alzheimer’s, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, Others), By Distribution Channel (Direct Sales v/s Indirect Sales), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Oral Clinical Nutrition Market is anticipated to expand from USD 16.96 Billion in 2025 to USD 23.91 Billion by 2031, reflecting a compound annual growth rate of 5.89%. This sector involves...
May 2026
185 pages
Plant Based Excipients Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Carbohydrates, Proteins, Polymers, Minerals, Glycoside & Waxes, Esters, Others), By Application (Binders & Diluents, Glidants, Lubricants & Disintegrants, Film Forming & Coating Agents, Plasticizers, Suspending Agents, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Plant Based Excipients Market is anticipated to expand from USD 2.41 Billion in 2025 to USD 3.11 Billion by 2031, representing a compound annual growth rate (CAGR) of 4.34%. Derived from na...
May 2026
189 pages
Osteoporosis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Route of Administration (Oral, Injectables, Others), By Drug Type (Parathyroid Hormone Therapy, Bisphosphonates, Calcitonin, Selective Estrogen Receptor Modulators, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global market for osteoporosis medications is expected to expand from USD 14.33 billion in 2025 to USD 18.38 billion by 2031, reflecting a compound annual growth rate of 4.24%. These pharmaceutica...
May 2026
180 pages
Clinical Nutrition Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Route of Administration (Oral, Intravenous), By Nutrition Type (Enteral Nutrition, Parental Nutrition), By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others), By End User (Infant & Child, Adults, Geriatrics), By Substrates (Energy, Carbohydrates, Lipids, Proteins & amino acids, Water & electrolyte, Dietary fiber, Antioxidants), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Clinical Nutrition Market is anticipated to expand from USD 34.09 billion in 2025 to USD 48.38 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.01%. This market involve...
May 2026
180 pages
Remdesivir Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Dosage Form (Lyophilized Solution, Frozen Solution), By Route of Administration (Intravenous, Inhalation), By Patient Age (Geriatric, Adult, Pediatric), By Application (SARS-CoV-2 (COVID-19), MERS-CoV, Ebola, SARS-CoV), By Distribution Channel (Hospitals, Clinics, Drug Stores and Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Remdesivir market is anticipated to expand from USD 4.92 billion in 2025 to USD 7.07 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.23%. Sold under the brand name Vek...
May 2026
180 pages
Global Dual GLP-1R/GIPR Agonist Market Growth 2026-2032
US$ 3,660.00
The global Dual GLP-1R/GIPR Agonist market size is predicted to grow from US$ 29966 million in 2025 to US$ 64976 million in 2032; it is expected to grow at a CAGR of 11.6% from 2026 to 2032. In 2025,...
April 2026
94 pages
Global Medical Electrolytes Market Growth 2026-2032
US$ 3,660.00
The global Medical Electrolytes market size is predicted to grow from US$ 11000 million in 2025 to US$ 16900 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032. Medical Electr...
April 2026
139 pages
Drug Discount Card Market Forecasts to 2034 – Global Analysis By Type (Pharmacy Benefit Managers (PBMs), Retail Pharmacy Chains, Direct-to-Consumer Platforms, Non-Profit Organizations and Other Types), By Therapeutic Category (Cardiovascular Drugs, Diabetes Drugs, Pain Medications and Other Therapeutic Categories), By Sales Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Drug Discount Card Market is accounted for $36.0 million in 2026 and is expected to reach $76.1million by 2034 growing at a CAGR of 9.8% during the forecast pe...
April 2026
200 pages
Dupuytren Disease Market Forecasts to 2034 – Global Analysis By Disease Type (Type I, Type II and Type III), Treatment (Needle Aponeurotomy, Surgery, Enzyme Injection, Radiation Therapy, Steroid Shot, Occupational Therapy and Other Treatments), Diagnosis, Route of Administration, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Dupuytren Disease Market is accounted for $5.3 billion in 2026 and is expected to reach $8.9 billion by 2034 growing at a CAGR of 6.6% during the forecast peri...
April 2026
200 pages
Muscle Relaxant Drug Market Forecasts to 2034 – Global Analysis By Drug Type (Neuromuscular Blocking Agents, Skeletal Muscle Relaxant Drugs and Facial Muscle Relaxant Drugs), Dosage Form (Capsule, Tablet, Liquid, Sprays and Gel and Ointments), Route Of Administration, Distribution Channel, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Muscle Relaxant Drug Market is accounted for $4.7 billion in 2026 and is expected to reach $7.6 billion by 2034 growing at a CAGR of 6.3% during the forecast p...
April 2026
200 pages
Myasthenia Gravis Disease Treatment Market Forecasts to 2034 – Global Analysis By Type (Generalized Myasthenia Gravis, Ocular Myasthenia Gravis, Transient Neonatal Myasthenia Gravis and Other Types), Drug Class (Cholinesterase Inhibitors, Monoclonal Antibodies, Corticosteroids, Immunosuppressants, Intravenous Immunoglobulins and Other Drug Classes), Treatment Modality, Distribution Channel and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Myasthenia Gravis Treatment Market is accounted for $2.8 billion in 2026 and is expected to reach $5.4 billion by 2034 growing at a CAGR of 8.5% during the for...
April 2026
200 pages
